<p><a href="http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20080409/bs_nm/pfizer_nektar_dc"><img src="http://d.yimg.com/us.yimg.com/p/nm/20080409/2008_04_09t085557_318x450_us_pfizer_nektar.jpg?x=9 1&y=130&q=85&sig=oM09paCDgIuCBfH.uNHR8g--" align="left" height="130" width="91" alt="A man stands inside the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels January 23, 2007. (Francois Lenoir/Reuters)" border="0" /></a>Reuters - Pfizer Inc and Nektar
Therapeutics said on Wednesday clinical trials of the
inhaled insulin Exubera found increased cases of lung cancer,
leading Nektar to stop seeking a marketing partner for the
troubled product and abandon it.</p><br clear="all"/>
View the entire article:
Pfizer warns of lung cancer with inhaled insulin
(Reuters)
Pfizer warns of lung cancer with inhaled insulin
(Reuters)
Linear Mode
